| Motif ID |
Motif Logo |
Scanned Score Distribution |
Frequency of Motif |
Replicability Score |
Evolutionary Conservation Score |
Gene Targets |
Gene Ontology of CpGMM targets |
| CG_h9laurent_promoter_n_PM_12_10_3 |
 |
 |
1 |
0.25 |
3.55E-05 |
DEGS2 |
sphingolipid delta-4 desaturase activity [MF],
sphingosine hydroxylase activity [MF] |
| CG_h9laurent_promoter_n_PM_12_8_2 |
 |
 |
1 |
0.25 |
1.92E-04 |
STK10 |
polo kinase kinase activity [MF] |
| CG_h9laurent_promoter_n_PM_16_7_14 |
 |
 |
4 |
0.75 |
6.52E-05 |
DUXA,
DLX2,
KLF4 |
transcription regulatory region DNA binding [MF],
transcription regulatory region sequence-specific DNA binding [MF] |
| CG_h9laurent_promoter_n_PM_12_29_5 |
 |
 |
2 |
0.5 |
3.28E-05 |
CACTIN |
negative regulation of interferon-beta production [BP],
negative regulation of type I interferon-mediated signaling pathway [BP] |
| CG_h9laurent_promoter_n_PM_20_3_6 |
 |
 |
1 |
0.25 |
5.30E-05 |
OLR1,
NEB,
ITGA5,
TNNC2,
NPFF,
TTLL7 |
perikaryon [CC],
leukocyte cell-cell adhesion [BP],
muscle filament sliding [BP] |
| CG_h9laurent_promoter_n_PM_14_23_3 |
 |
 |
2 |
0.5 |
2.22E-05 |
PDF |
peptide deformylase activity [MF] |
| CG_h9laurent_promoter_n_PM_14_14_4 |
 |
 |
1 |
0.25 |
3.28E-05 |
NRARP |
blood vessel endothelial cell proliferation involved in sprouting angiogenesis [BP] |
| CG_h9laurent_promoter_n_PM_12_31_2 |
 |
 |
2 |
0.5 |
9.21E-05 |
HELZ2,
EIF2S2,
PDGFA |
negative regulation of phosphatidylinositol biosynthetic process [BP],
eukaryotic translation initiation factor 2 complex [CC],
RNA binding [MF],
regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling [BP],
positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway [BP] |
| CG_h9laurent_promoter_n_PM_12_37_2 |
 |
 |
3 |
0.75 |
2.50E-05 |
GOT2 |
L-aspartate:2-oxoglutarate aminotransferase activity [MF] |
| CG_h9laurent_promoter_n_PM_20_1_3 |
 |
 |
1 |
0.25 |
2.32E-05 |
DTYMK,
RRM2B |
deoxyribonucleotide biosynthetic process [BP],
deoxyribonucleoside triphosphate metabolic process [BP],
cell cycle [BP],
deoxyribonucleoside diphosphate metabolic process [BP],
nucleoside phosphate kinase activity [MF],
nucleoside monophosphate phosphorylation [BP],
nucleobase-containing small molecule interconversion [BP] |
| CG_h9laurent_promoter_n_PM_20_9_4 |
 |
 |
1 |
0.25 |
1.01E-04 |
PLXNB1,
CCBL1,
BRF1,
GMIP,
IL22 |
glutamine-phenylpyruvate transaminase activity [MF],
positive regulation of Rho GTPase activity [BP],
interleukin-22 receptor binding [MF],
L-phenylalanine:pyruvate aminotransferase activity [MF],
L-phenylalanine-oxaloacetate transaminase activity [MF],
transcription factor TFIIIB complex [CC],
L-glutamine:pyruvate aminotransferase activity [MF] |
| CG_h9laurent_promoter_n_PM_12_19_3 |
 |
 |
2 |
0.5 |
7.10E-05 |
MUT,
RLBP1 |
methylmalonyl-CoA mutase activity [MF],
11-cis retinal binding [MF] |
| CG_h9laurent_promoter_n_PM_14_10_3 |
 |
 |
2 |
0.5 |
1.00E-04 |
PRDX1,
ACOT8,
GLDC |
choloyl-CoA hydrolase activity [MF],
glycine dehydrogenase (decarboxylating) activity [MF],
peroxisomal matrix [CC] |
| CG_h9laurent_promoter_n_PM_20_5_4 |
 |
 |
1 |
0.25 |
4.67E-05 |
QARS,
B3GALNT2,
PLOD3,
TWF2 |
procollagen glucosyltransferase activity [MF],
glutamine-tRNA ligase activity [MF],
glutaminyl-tRNA aminoacylation [BP],
galactosyltransferase activity [MF],
regulation of microvillus length [BP] |
| CG_h9laurent_promoter_n_PM_12_33_4 |
 |
 |
1 |
0.25 |
4.08E-05 |
ABCA2 |
regulation of intracellular cholesterol transport [BP] |
| CG_h9laurent_promoter_n_PM_12_26_2 |
 |
 |
2 |
0.5 |
2.03E-04 |
KRT9,
KRT14,
SOHLH1,
PLD6,
KRT16 |
oogenesis [BP],
spermatogenesis [BP],
intermediate filament cytoskeleton organization [BP],
P granule organization [BP],
structural constituent of cytoskeleton [MF],
intermediate filament [CC],
cardiolipin hydrolase activity [MF],
intermediate filament organization [BP],
epidermis development [BP] |
| CG_h9laurent_promoter_n_PM_20_22_4 |
 |
 |
1 |
0.25 |
7.00E-05 |
RANGAP1,
POMGNT1 |
beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity [MF],
positive regulation of Ran GTPase activity [BP],
Ran GTPase activator activity [MF] |
| CG_h9laurent_promoter_n_PM_12_22_2 |
 |
 |
2 |
0.5 |
4.94E-05 |
MITD1 |
cytokinetic cell separation involved in cell cycle cytokinesis [BP] |
| CG_h9laurent_promoter_n_PM_18_10_12 |
 |
 |
1 |
0.25 |
7.04E-05 |
TEX14,
CS |
intercellular bridge organization [BP],
citrate (Si)-synthase activity [MF] |
| CG_h9laurent_promoter_n_PM_16_13_2 |
 |
 |
3 |
0.75 |
4.03E-05 |
MED1,
ANKRD54,
SNRPG,
CPSF1,
IL4I1 |
termination of RNA polymerase II transcription [BP],
nucleocytoplasmic transport [BP],
L-amino-acid oxidase activity [MF],
enucleate erythrocyte development [BP],
thyroid hormone mediated signaling pathway [BP] |
| CG_h9laurent_promoter_n_PM_14_20_5 |
 |
 |
6 |
1.0 |
9.12E-05 |
STX1A |
myosin head/neck binding [MF] |
| CG_h9laurent_promoter_n_PM_12_24_3 |
 |
 |
1 |
0.25 |
6.79E-05 |
MESP1,
LEO1 |
negative regulation of endodermal cell fate specification [BP],
positive regulation of Notch signaling pathway involved in heart induction [BP],
cardiac atrium formation [BP],
cardioblast migration to the midline involved in heart field formation [BP],
cardioblast anterior-lateral migration [BP],
sinus venosus morphogenesis [BP],
endodermal cell fate commitment [BP] |
| CG_h9laurent_promoter_n_PM_12_17_2 |
 |
 |
3 |
0.75 |
1.17E-04 |
AGO2,
AXIN1 |
canonical Wnt receptor signaling pathway involved in neural plate anterior/posterior pattern formation [BP],
endoribonuclease activity, cleaving siRNA-paired mRNA [MF],
mRNA cleavage involved in gene silencing by miRNA [BP],
Wnt receptor signaling pathway involved in forebrain neuron fate commitment [BP] |
| CG_h9laurent_promoter_n_PM_12_4_3 |
 |
 |
1 |
0.25 |
3.29E-05 |
SDF4,
FASN,
PPP1CA,
SLC2A5 |
3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity [MF],
3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity [MF],
enoyl-[acyl-carrier-protein] reductase (NADPH, B-specific) activity [MF],
[acyl-carrier-protein] S-acetyltransferase activity [MF],
zymogen granule exocytosis [BP],
fructose transport [BP],
3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [MF],
fructose transmembrane transporter activity [MF],
glycogen granule [CC] |
| CG_h9laurent_promoter_n_PM_12_9_1 |
 |
 |
2 |
0.5 |
1.04E-04 |
IRF3 |
MDA-5 signaling pathway [BP] |
| CG_h9laurent_promoter_n_PM_14_9_3 |
 |
 |
1 |
0.25 |
3.22E-05 |
SPI1,
DDX23 |
cis assembly of pre-catalytic spliceosome [BP],
negative regulation of histone H4 acetylation [BP] |
| CG_h9laurent_promoter_n_PM_12_36_4 |
 |
 |
2 |
0.5 |
1.36E-05 |
TFRC,
RAB35 |
coated pit [CC] |
| CG_h9laurent_promoter_n_PM_12_13_3 |
 |
 |
2 |
0.5 |
2.30E-04 |
SIN3A,
SOX18 |
response to methylglyoxal [BP],
stem cell fate specification [BP],
negative regulation of histone H3-K27 acetylation [BP] |
| CG_h9laurent_promoter_n_PM_16_5_2 |
 |
 |
1 |
0.25 |
5.93E-05 |
PGGT1B |
CAAX-protein geranylgeranyltransferase complex [CC] |
| CG_h9laurent_promoter_n_PM_18_1_13 |
 |
 |
1 |
0.25 |
8.61E-05 |
PELI1,
PSME4 |
positive regulation of protein ubiquitination [BP],
protein polyubiquitination [BP] |
| CG_h9laurent_promoter_n_PM_18_3_20 |
 |
 |
2 |
0.25 |
2.36E-05 |
RNH1 |
angiogenin-PRI complex [CC],
ribonuclease inhibitor activity [MF] |
| CG_h9laurent_promoter_n_PM_20_4_4 |
 |
 |
1 |
0.25 |
4.70E-05 |
SHPK,
COBL |
cellular response to interleukin-13 [BP],
sedoheptulokinase activity [MF],
actin filament network formation [BP] |
| CG_h9laurent_promoter_n_PM_12_2_4 |
 |
 |
2 |
0.5 |
3.94E-05 |
STAR |
cellular response to luteinizing hormone stimulus [BP] |
| CG_h9laurent_promoter_n_PM_16_3_5 |
 |
 |
2 |
0.5 |
1.20E-05 |
TNK2 |
Grb2-EGFR complex [CC] |
| CG_h9laurent_promoter_n_PM_12_30_4 |
 |
 |
3 |
0.75 |
1.97E-04 |
BCL2,
ANAPC5 |
negative regulation of cellular pH reduction [BP],
CD8-positive, alpha-beta T cell lineage commitment [BP],
positive regulation of neuron maturation [BP],
negative regulation of mitochondrial depolarization [BP],
positive regulation of skeletal muscle fiber development [BP],
negative regulation of retinal cell programmed cell death [BP],
cochlear nucleus development [BP],
protein phosphatase binding [MF] |
| CG_h9laurent_promoter_n_PM_14_7_5 |
 |
 |
3 |
0.5 |
2.31E-05 |
DNAJC17,
HNRNPR,
BCAT2,
PUM2 |
RNA binding [MF],
isoleucine catabolic process [BP],
L-leucine transaminase activity [MF],
branched-chain-amino-acid transaminase activity [MF],
L-isoleucine transaminase activity [MF],
branched-chain amino acid biosynthetic process [BP],
L-valine transaminase activity [MF] |
| CG_h9laurent_promoter_n_PM_18_4_6 |
 |
 |
1 |
0.25 |
6.71E-05 |
NUDT3,
RS1,
DCT |
diphosphoinositol polyphosphate catabolic process [BP],
melanin biosynthetic process from tyrosine [BP],
diadenosine polyphosphate catabolic process [BP],
adaptation of rhodopsin mediated signaling [BP] |
| CG_h9laurent_promoter_n_PM_18_9_5 |
 |
 |
1 |
0.25 |
4.59E-05 |
FGF8,
SHPK |
cellular response to interleukin-13 [BP],
cell migration involved in mesendoderm migration [BP] |
| CG_h9laurent_promoter_n_PM_14_2_3 |
 |
 |
3 |
0.75 |
4.56E-05 |
MBOAT1,
LPCAT3,
GATM |
phosphatidylserine acyl-chain remodeling [BP],
phosphatidylethanolamine acyl-chain remodeling [BP],
glycine amidinotransferase activity [MF] |
| CG_h9laurent_promoter_n_PM_18_15_4 |
 |
 |
1 |
0.25 |
8.61E-05 |
UQCC,
MRPL47,
ATP6V1E1,
MRPL11,
CRAT |
carnitine O-acetyltransferase activity [MF],
mitochondrial ribosome [CC],
mitochondrion [CC] |
| CG_h9laurent_promoter_n_PM_16_25_6 |
 |
 |
2 |
0.5 |
1.86E-05 |
TKT,
PLD6,
AHCTF1,
NUP88 |
glyceraldehyde-3-phosphate biosynthetic process [BP],
nuclear pore [CC],
cardiolipin hydrolase activity [MF] |
| CG_h9laurent_promoter_n_PM_18_7_4 |
 |
 |
1 |
0.25 |
7.63E-05 |
EEF1A2 |
eukaryotic translation elongation factor 1 complex [CC] |
| CG_h9laurent_promoter_n_PM_12_7_4 |
 |
 |
2 |
0.5 |
5.89E-05 |
SFRP5,
TPMT,
PES1,
ABRA,
TMEM173,
RPS6KA2 |
cyclic-di-GMP binding [MF],
thiopurine S-methyltransferase activity [MF],
protein localization to organelle [BP],
protein import into nucleus, translocation [BP],
negative regulation of Wnt receptor signaling pathway involved in digestive tract morphogenesis [BP],
mitotic metaphase [BP] |
| CG_h9laurent_promoter_n_PM_14_3_4 |
 |
 |
2 |
0.5 |
1.94E-05 |
AKR7A2 |
phenanthrene-9,10-epoxide hydrolase activity [MF] |
| CG_h9laurent_promoter_n_PM_12_5_2 |
 |
 |
1 |
0.25 |
6.94E-05 |
CTSD,
CD74 |
macrophage migration inhibitory factor binding [MF],
macrophage migration inhibitory factor receptor complex [CC],
lysosomal lumen [CC],
NOS2-CD74 complex [CC],
macrophage migration inhibitory factor signaling pathway [BP] |
| CG_h9laurent_promoter_n_PM_14_5_3 |
 |
 |
2 |
0.5 |
2.69E-05 |
ST3GAL5,
TRABD2A,
DBN1 |
neolactotetraosylceramide alpha-2,3-sialyltransferase activity [MF],
integral to organelle membrane [CC],
cell communication by chemical coupling [BP],
lactosylceramide alpha-2,3-sialyltransferase activity [MF] |
| CG_h9laurent_promoter_n_PM_20_21_3 |
 |
 |
1 |
0.25 |
5.36E-05 |
CHRNA10,
GFI1 |
inner ear morphogenesis [BP],
positive regulation of interleukin-6-mediated signaling pathway [BP] |
| CG_h9laurent_promoter_n_PM_12_3_2 |
 |
 |
1 |
0.25 |
4.01E-05 |
DPM2,
LIF |
protein O-linked mannosylation [BP],
leukemia inhibitory factor signaling pathway [BP],
leukemia inhibitory factor receptor binding [MF],
positive regulation of peptidyl-serine phosphorylation of STAT protein [BP],
positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis [BP],
positive regulation of protein localization to nucleus [BP],
positive regulation of histone H3-K27 acetylation [BP],
spongiotrophoblast differentiation [BP],
RNA polymerase II transcription factor recruiting transcription factor activity [MF],
dolichyl-phosphate beta-D-mannosyltransferase activity [MF],
dolichol metabolic process [BP] |
| CG_h9laurent_promoter_n_PM_14_31_3 |
 |
 |
3 |
0.75 |
4.70E-05 |
DUSP3 |
positive regulation of mitotic cell cycle [BP] |
| CG_h9laurent_promoter_n_PM_16_1_5 |
 |
 |
3 |
0.5 |
7.45E-05 |
GSK3A,
SLC27A5 |
negative regulation of UDP-glucose catabolic process [BP],
cholate-CoA ligase activity [MF] |
| CG_h9laurent_promoter_n_PM_20_13_4 |
 |
 |
1 |
0.25 |
7.44E-05 |
MAP4,
PPAP2B |
canonical Wnt receptor signaling pathway involved in positive regulation of endothelial cell migration [BP],
canonical Wnt receptor signaling pathway involved in positive regulation of wound healing [BP],
microtubule sliding [BP],
canonical Wnt receptor signaling pathway involved in positive regulation of cell-cell adhesion [BP] |
| CG_h9laurent_promoter_n_PM_16_4_4 |
 |
 |
3 |
0.5 |
4.13E-05 |
TIMP2,
SLC33A1,
ARSA |
cerebroside-sulfatase activity [MF],
negative regulation of mitotic cell cycle [BP],
acetyl-CoA transporter activity [MF],
acetyl-CoA transport [BP] |
| CG_h9laurent_promoter_n_PM_16_2_8 |
 |
 |
3 |
0.5 |
1.43E-05 |
CHST15 |
N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [MF] |
| CG_h9laurent_promoter_n_PM_14_12_3 |
 |
 |
1 |
0.25 |
1.02E-04 |
NCOR1 |
regulation of glycolysis by negative regulation of transcription from RNA polymerase II promoter [BP],
regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter [BP] |
| CG_h9laurent_promoter_n_PM_16_24_4 |
 |
 |
1 |
0.25 |
2.39E-05 |
CBS,
ST6GALNAC6,
CKM |
cystathionine beta-synthase activity [MF],
alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity [MF],
cysteine biosynthetic process via cystathionine [BP],
homocysteine catabolic process [BP],
transsulfuration [BP],
cysteine biosynthetic process from serine [BP],
hydrogen sulfide biosynthetic process [BP],
phosphocreatine biosynthetic process [BP] |
| CG_h9laurent_promoter_n_PM_20_11_6 |
 |
 |
1 |
0.25 |
7.07E-05 |
CELF1,
SNRPG |
BRE binding [MF],
spliceosomal complex assembly [BP] |
| CG_h9laurent_promoter_n_PM_16_16_5 |
 |
 |
2 |
0.5 |
6.81E-05 |
TTLL1,
ATP5H,
TPST2,
INO80,
ALG3 |
tubulin-glutamic acid ligase activity [MF],
positive regulation of DNA replication involved in S phase [BP],
protein-tyrosine sulfotransferase activity [MF],
dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity [MF],
ATP catabolic process [BP],
peptidyl-tyrosine sulfation [BP] |
| CG_h9laurent_promoter_n_PM_14_6_4 |
 |
 |
3 |
0.75 |
1.04E-04 |
M1AP,
CELF1,
G6PD |
BRE binding [MF],
glucose-6-phosphate dehydrogenase activity [MF],
male meiosis chromosome separation [BP],
negative regulation of protein glutathionylation [BP] |
| CG_h9laurent_promoter_n_PM_16_10_3 |
 |
 |
1 |
0.25 |
5.59E-06 |
GBGT1 |
globoside alpha-N-acetylgalactosaminyltransferase activity [MF] |
| CG_h9laurent_promoter_n_PM_18_6_9 |
 |
 |
1 |
0.25 |
2.78E-05 |
RNF168,
ROCK2,
EXOSC3 |
isotype switching [BP],
histone H2A-K15 ubiquitination [BP],
histone H2A-K13 ubiquitination [BP],
positive regulation of centrosome duplication [BP] |
| CG_h9laurent_promoter_n_PM_20_15_6 |
 |
 |
1 |
0.25 |
5.13E-05 |
HIPK2,
NPLOC4,
LRP6,
POFUT2,
IKBIP |
embryonic retina morphogenesis in camera-type eye [BP],
endoplasmic reticulum [CC],
embryonic camera-type eye morphogenesis [BP] |
| CG_h9laurent_promoter_n_PM_14_32_3 |
 |
 |
2 |
0.5 |
2.37E-05 |
PLD6 |
P granule organization [BP],
cardiolipin hydrolase activity [MF] |
| CG_h9laurent_promoter_n_PM_14_26_3 |
 |
 |
3 |
0.75 |
1.82E-04 |
CELF1 |
BRE binding [MF] |
| CG_h9laurent_promoter_n_PM_18_13_5 |
 |
 |
1 |
0.25 |
4.00E-05 |
VGF,
SLC35B1 |
response to cold [BP],
transport [BP] |
| CG_h9laurent_promoter_n_PM_16_9_5 |
 |
 |
1 |
0.25 |
6.10E-05 |
CRLF1 |
negative regulation of motor neuron apoptotic process [BP] |
| CG_h9laurent_promoter_n_PM_14_18_3 |
 |
 |
2 |
0.5 |
5.28E-05 |
COL7A1 |
collagen type VII [CC] |
| CG_h9laurent_promoter_n_PM_20_17_4 |
 |
 |
1 |
0.25 |
8.89E-05 |
HID1 |
Golgi medial cisterna [CC],
response to brefeldin A [BP],
extrinsic to Golgi membrane [CC] |
| CG_h9laurent_promoter_n_PM_16_21_4 |
 |
 |
1 |
0.25 |
2.33E-05 |
SNTA1,
ABR,
ICAM2,
SUMO1 |
regulation of immune response [BP],
negative regulation of neutrophil degranulation [BP],
protein localization to nuclear pore [BP],
regulation of vasoconstriction by circulating norepinephrine [BP] |
| CG_h9laurent_promoter_n_PM_18_2_3 |
 |
 |
2 |
0.25 |
1.43E-05 |
PLA2G16,
PNPT1 |
mitochondrial mRNA polyadenylation [BP],
nuclear polyadenylation-dependent mRNA catabolic process [BP],
positive regulation of miRNA catabolic process [BP],
mitochondrial RNA 5'-end processing [BP],
mitochondrial degradosome [CC],
phosphatidylserine 1-acylhydrolase activity [MF],
1-acyl-2-lysophosphatidylserine acylhydrolase activity [MF],
polyribonucleotide nucleotidyltransferase activity [MF] |
| CG_h9laurent_promoter_n_PM_14_30_4 |
 |
 |
3 |
0.75 |
6.23E-05 |
DDX17,
FAT1,
ATAD1,
FRRS1L |
cell-cell junction [CC],
cell junction [CC],
RNA helicase activity [MF],
RNA-dependent ATPase activity [MF] |
| CG_h9laurent_promoter_n_PM_14_28_3 |
 |
 |
1 |
0.25 |
5.80E-05 |
SLC12A6 |
cellular hypotonic salinity response [BP] |
| CG_h9laurent_promoter_n_PM_12_28_2 |
 |
 |
2 |
0.5 |
5.75E-05 |
GRIK5,
BST2,
LSM4 |
regulation of synaptic vesicle fusion to presynaptic membrane [BP],
negative regulation of egress of virus within host cell [BP],
negative regulation of plasmacytoid dendritic cell cytokine production [BP],
U6 snRNP [CC] |
| CG_h9laurent_promoter_n_PM_12_38_4 |
 |
 |
3 |
0.75 |
2.58E-04 |
PDLIM7,
PECR |
phytol metabolic process [BP],
ruffle [CC] |
| CG_h9laurent_promoter_n_PM_14_13_2 |
 |
 |
1 |
0.25 |
2.91E-05 |
AGMAT,
SLBP |
putrescine biosynthetic process from arginine [BP],
agmatinase activity [MF],
regulation of S phase [BP] |
| CG_h9laurent_promoter_n_PM_16_18_3 |
 |
 |
2 |
0.5 |
4.21E-05 |
TBX5,
DRD1 |
dopamine neurotransmitter receptor activity, coupled via Gs [MF],
cardiac left ventricle formation [BP],
sensitization [BP],
cell migration involved in coronary vasculogenesis [BP] |
| CG_h9laurent_promoter_n_PM_14_11_5 |
 |
 |
4 |
0.75 |
7.04E-05 |
TIPIN,
SLBP |
DNA replication involved in S phase [BP],
regulation of S phase [BP] |
| CG_h9laurent_promoter_n_PM_18_17_13 |
 |
 |
1 |
0.25 |
3.26E-05 |
PNKP,
NGLY1 |
peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity [MF],
polynucleotide 3'-phosphatase activity [MF],
nucleotide phosphorylation [BP] |
| CG_h9laurent_promoter_n_PM_20_18_2 |
 |
 |
1 |
0.25 |
1.10E-04 |
EIF5A2,
DEGS2,
TAT |
sphingolipid delta-4 desaturase activity [MF],
L-tyrosine:2-oxoglutarate aminotransferase activity [MF],
polyamine homeostasis [BP],
sphingosine hydroxylase activity [MF] |
| CG_h9laurent_promoter_n_PM_20_10_8 |
 |
 |
1 |
0.25 |
3.42E-05 |
FA2H |
sebaceous gland cell differentiation [BP],
fatty acid alpha-hydroxylase activity [MF] |
| CG_h9laurent_promoter_n_PM_14_17_4 |
 |
 |
2 |
0.5 |
1.66E-05 |
AXIN1,
LZIC |
canonical Wnt receptor signaling pathway involved in neural plate anterior/posterior pattern formation [BP],
beta-catenin binding [MF],
Wnt receptor signaling pathway involved in forebrain neuron fate commitment [BP] |
| CG_h9laurent_promoter_n_PM_12_16_4 |
 |
 |
2 |
0.5 |
8.93E-05 |
HCN4,
LAMP3 |
intracellular cAMP activated cation channel activity [MF],
alveolar lamellar body membrane [CC] |
| CG_h9laurent_promoter_n_PM_12_25_3 |
 |
 |
1 |
0.25 |
7.04E-05 |
ENTPD4,
INTS1 |
UDP catabolic process [BP],
U2 snRNA 3'-end processing [BP] |
| CG_h9laurent_promoter_n_PM_20_12_3 |
 |
 |
1 |
0.25 |
3.57E-05 |
GGCX,
NDUFAB1 |
ACP phosphopantetheine attachment site binding involved in fatty acid biosynthetic process [MF],
gamma-glutamyl carboxylase activity [MF] |
| CG_h9laurent_promoter_n_PM_12_18_4 |
 |
 |
4 |
0.75 |
6.59E-05 |
DCTD,
NT5C |
pyrimidine nucleotide metabolic process [BP],
pyrimidine nucleobase metabolic process [BP] |
| CG_h9laurent_promoter_n_PM_12_14_3 |
 |
 |
3 |
0.75 |
3.20E-05 |
GSK3A,
CTSH |
negative regulation of type B pancreatic cell development [BP],
negative regulation of cell growth involved in cardiac muscle cell development [BP],
neuropeptide catabolic process [BP],
positive regulation of adrenergic receptor signaling pathway [BP],
negative regulation of UDP-glucose catabolic process [BP],
HLA-A specific activating MHC class I receptor activity [MF] |
| CG_h9laurent_promoter_n_PM_16_11_10 |
 |
 |
2 |
0.5 |
4.34E-05 |
PELI1 |
positive regulation of toll-like receptor 3 signaling pathway [BP] |
| CG_h9laurent_promoter_n_PM_16_20_5 |
 |
 |
1 |
0.25 |
7.75E-05 |
AICDA,
MYO18A |
DNA metabolic process [BP],
negative regulation of methylation-dependent chromatin silencing [BP] |
| CG_h9laurent_promoter_n_PM_20_14_7 |
 |
 |
1 |
0.25 |
3.50E-05 |
EPHA2,
RPGRIP1L |
notochord cell development [BP],
thromboxane A2 receptor binding [MF] |
| CG_h9laurent_promoter_n_PM_14_27_3 |
 |
 |
2 |
0.5 |
3.32E-05 |
AP3D1,
SLC9A1,
NT5C2,
RELA |
sodium ion export [BP],
antigen processing and presentation, exogenous lipid antigen via MHC class Ib [BP],
nucleoside phosphotransferase activity [MF],
positive regulation of Schwann cell differentiation [BP],
synaptic vesicle membrane organization [BP],
response to cobalamin [BP],
acetaldehyde metabolic process [BP],
response to acid [BP] |
| CG_h9laurent_promoter_n_PM_12_23_3 |
 |
 |
1 |
0.25 |
2.55E-05 |
ZER1,
IP6K3 |
vacuolar proton-transporting V-type ATPase, V1 domain [CC],
inositol hexakisphosphate 6-kinase activity [MF] |
| CG_h9laurent_promoter_n_PM_20_16_4 |
 |
 |
1 |
0.25 |
1.13E-04 |
TEX14,
OIP5,
NUDCD2 |
chromosome, centromeric region [CC],
mitotic sister chromatid separation [BP],
kinetochore [CC],
intercellular bridge organization [BP],
condensed chromosome kinetochore [CC] |
| CG_h9laurent_promoter_n_PM_14_19_7 |
 |
 |
2 |
0.5 |
1.74E-05 |
PPP4R1 |
protein phosphatase type 4 regulator activity [MF] |